American Society of Hirudotherapy

Macrostomin

Antimicrobial peptide active against Gram-positive bacteria — amphipathic alpha-helix.

Preclinical / mechanisticLast updated: 2026-05-26 · Reviewed by ASH Editorial Board
Molecular weight of Macrostomin compared with other characterized leech-derived compoundsHementerin80 kDaHementin80 kDaHementin-Like Protein (HLP-1)80 kDaLeech Collagenase70 kDaHaemadipsa yanyuanensis Progr…70 kDaLeech Apyrase67 kDaCalin65 kDaHyaluronidase60 kDaAntithrombin III binding prot…58 kDaCollagenolytic Fibrinolysin55 kDaLeech Thrombospondin-Like Pro…50 kDaMacrostomin2.9 kDa
Molecular weight (kilodaltons) of Macrostomin (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic
Page type
Compound profile
Evidence type
Antimicrobial peptide active against Gram-positive bacteria — amphipathic alpha-helix.
Evidence level
In vitro
Drug vs leech
Purified natural compound

Clinical translation limit

Macrostomin's in vitro antimicrobial activity does not establish clinical efficacy as a therapeutic antibiotic. No FDA-approved derivative exists. Mechanism is preclinical/biochemical only.

Molecular Profile

Category
Antimicrobial
Evidence tier
Preclinical
Molecular weight
2,900 Da
Source species
Macrobdella decora
Macrostomin molecular structure

Biological Targets

  • Gram-positive bacterial membranes

External Resources

    Related Antimicrobial Compounds

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.